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Despite the absence of responsiveness during anesthesia, conscious experience may persist. However, reliable,
easily acquirable and interpretable neurophysiological markers of the presence of consciousness in unresponsive
states are still missing. A promising marker is based on the decay-rate of the power spectral density (PSD) of the
resting EEG.
We acquired resting electroencephalogram (EEG) in three groups of healthy participants (n¼ 5 each), before
and during anesthesia induced by either xenon, propofol or ketamine. Dosage of each anesthetic agent was
tailored to yield unresponsiveness (Ramsay score¼ 6). Delayed subjective reports assessed whether conscious
experience was present (‘Conscious report’) or absent/inaccessible to recall (‘No Report’). We estimated the decay
of the PSD of the resting EEG—after removing oscillatory peaks—via the spectral exponent β, for a broad band
(1–40 Hz) and narrower sub-bands (1–20 Hz, 20–40 Hz). Within-subject anesthetic changes in β were assessed.
Furthermore, based on β, ‘Conscious report’ states were discriminated against ‘no report’ states. Finally, we
evaluated the correlation of the resting spectral exponent with a recently proposed index of consciousness, the
Perturbational Complexity Index (PCI), derived from a previous TMS-EEG study.
The spectral exponent of the resting EEG discriminated states in which consciousness was present (wakefulness,
ketamine) from states where consciousness was reduced or abolished (xenon, propofol). Loss of consciousness
substantially decreased the (negative) broad-band spectral exponent in each subject undergoing xenon or propofol
anesthesia—indexing an overall steeper PSD decay. Conversely, ketamine displayed an overall PSD decay similar
to that of wakefulness—consistent with the preservation of consciousness—yet it showed a ﬂattening of the decay
in the high-frequencies (20–40 Hz)—consistent with its speciﬁc mechanism of action. The spectral exponent was
highly correlated to PCI, corroborating its interpretation as a marker of the presence of consciousness. A steeper
PSD of the resting EEG reliably indexed unconsciousness in anesthesia, beyond sheer unresponsiveness.Colombo), simone.sarasso@unimi.it (S. Sarasso).
form 20 December 2018; Accepted 9 January 2019
vier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
M.A. Colombo et al. NeuroImage 189 (2019) 631–6441. Introduction
In clinical practice, behavioural unresponsiveness is often interpreted
as indirect evidence for the absence of consciousness (Giacino et al.,
2004; Jones, 1979). Accordingly, behavioural unresponsiveness induced
by general anesthesia is commonly associated with loss of consciousness.
However, multiple lines of evidence support the notion that conscious-
ness can be preserved in subjects who are disconnected from the envi-
ronment—due to a blockade of sensorimotor pathways—thus pointing to
behavioural unresponsiveness as an unreliable marker of the absence of
consciousness (Sanders et al., 2012). Therefore, the development of an
objective neurophysiological marker of consciousness, independently
from behavioural responsiveness, is deemed necessary (Koch et al.,
2016).
1.1. Unconsciousness is linked to EEG slowing, yet oscillations are
unspeciﬁc for unconsciousness
A typical electrophysiological feature associated with the fading of
consciousness is a redistribution of EEG spectral power from higher to
lower frequencies, a phenomenon known as ‘EEG slowing’ (Oken et al.,
2006; Steyn-Ross et al., 2004). This phenomenon has been observed
during the transition from wakefulness to sleep (Merica and Blois, 1997;
De Gennaro et al., 2001; Ogilvie, 2001), during anesthetic-induced loss of
consciousness (as reviewed in (Brown et al., 2010)) and in severe dis-
orders of consciousness (Chennu et al., 2014; Estraneo et al., 2016; Sitt
et al., 2014; Coleman et al., 2005; Lechinger et al., 2013).
However, beyond an overall frequency slowing, different anaesthetics
are associated with the emergence of different oscillatory peaks in the
power spectral density (PSD). More generally, peaks of the PSD,
reﬂecting oscillations in different frequency bands, can occur across
vigilance states: theta rhythm during drowsiness (Finelli et al., 2000;
Hung et al., 2013), REM sleep, ketamine anesthesia, sevoﬂurane anes-
thesia; alpha rhythm in eyes closed wakefulness, drowsiness, REM sleep,
propofol or sevoﬂurane anesthesia; sigma rhythm during quiet wake-
fulness, deep NREM sleep, benzodiazepines sedation; high-beta rhythms
during ketamine-anesthesia and REM sleep (Purdon et al., 2015; Cantero
et al., 2002). The presence of such oscillations might have hindered the
attempts to develop a general and reliable neurophysiological marker of
unconsciousness based on EEG spectral power (Purdon et al., 2015). On
the other hand, promising EEG measures based on effective connectivity
(Juel et al., 2018) and multi-scale temporal complexity (Miskovic et al.,
2018) have been recently proposed. Interestingly, the latter was associ-
ated with the spectral exponent, a measure that captures the overall
slowing of the EEG across frequencies, while being minimally inﬂuenced
by oscillatory peaks.
1.2. Non-oscillatory, 1/f-like activity constitutes the background of
neurophysiological signals
Underneath oscillatory peaks, the 'background' of the PSD decays
from slower to faster frequencies, according to an inverse power-law,
with a 1/f-like shape (He et al., 2010). The spectral exponent—esti-
mated from the slope of the PSD in log-log coordinates—indexes the
steepness of the decay of the PSD background. This background could
originate from truly arrhythmic activity (Juel et al., 2018), or from
quasi-periodic activity (brief oscillations that vary in frequency),
measured over a broad spatial or temporal scale (Palva and Palva, 2018).
Whatever the precise origin of the 1/f-like shape, similar inverse
power-law behaviour has been observed for neural activity across
different spatial-scales (He, 2014), e.g. in membrane potential ﬂuctua-
tions (Destexhe et al., 2003), in local ﬁeld potentials (Milstein et al.,
2009; Buzsaki and Mizuseki, 2014), in electrocorticography (ECoG) (He
et al., 2010; Miller et al., 2009; Manning et al., 2009; Freeman and Zhai,
2009), in magnetoencephalography (MEG) (Novikov et al., 1997; Deh-
ghani et al., 2010), and fMRI (He, 2011; Ciuciu et al., 2012).6321.3. The EEG spectral exponent is linked to the balance between excitation
and inhibition
The spectral exponent has been recently linked to the balance be-
tween excitation and inhibition in neuronal signalling, using one in-silico
and three different in-vivo models (Gao et al., 2017). In one of these
models, the spectral exponent reliably tracked the induction and the
recovery from propofol-anesthesia in a pharmacological experiment with
macaques (Gao et al., 2017).
Physiologically, the balance between excitation and inhibition
changes dramatically during sleep. Consistently, the spectral exponent of
the EEG diminishes with sleep depth, displaying more negative values as
sleep deepens (Miskovic et al., 2018; Pereda et al., 1998; Robinson et al.,
2001; Shen et al., 2003). The spectral exponent observed in slow-wave
sleep was substantially more negative than in wakefulness, both in EEG
(Freeman, 2006) and ECoG recordings (He et al., 2010; Freeman and
Zhai, 2009). Interestingly, the spectral exponent of the only ECoG
recording obtained during REM sleep had a similar value to those of
wakefulness (He et al., 2010). This observation is consistent with the
observation in rats of a steeper PSD decay during NREM sleep, as
compared to that of REM and wakefulness (Leemburg et al., 2018).
Another study found slightly more negative EEG spectral exponent values
during sleep onset with respect to quiet wakefulness, as well as a decrease
of the exponent over time, as sleep onset progressed (Susmakova, 2006).
Furthermore, the PSD of the EEG became progressively steeper from REM
sleep, through sleep stage 2, to slow-wave sleep (Miskovic et al., 2018;
Pereda et al., 1998; Shen et al., 2003).
In sum, vigilance states commonly associated with the presence of
consciousness (wakefulness, REM, sleep-onset period)—despite variable
degrees of sensorimotor connectedness—were characterized by a similar
shallow decay of the PSD. In contrast, deep sleep and anesthesia-induced
loss of consciousness steepened the decay of the PSD.
Thus, we hypothesized that, irrespectively of the presence of oscil-
latory spectral peaks, a common change happening during anesthetic-
induced loss of consciousness is that the broad-band background shape
of the PSD becomes more narrow and steep, yielding more negative
values of the spectral exponent β. For this purpose, we employed three
anesthetic agents with different and complementary mechanisms of
action—namely xenon, propofol and ketamine—at high doses, individ-
ually tailored to render participants equally unresponsive. We then
investigated drug-speciﬁc effects on the EEG spectral exponent β.
Moreover, we evaluated the effectiveness of β in discriminating the
presence/absence of conscious experience—based upon reports assessed
either immediately or upon awakening from unresponsiveness. Finally,
we assessed how the resting-EEG spectral exponent correlated with the
Perturbational Complexity Index (PCI), acquired contextually in the same
subjects (Sarasso et al., 2015). PCI is based upon the evoked EEG
response to transcranial magnetic stimulation (TMS), and represents
another marker of consciousness, independent of sensory processing and
behavioural responsiveness (Casali et al., 2013; Casarotto et al., 2016).
2. Materials and methods
2.1. Participants
Data analysed in the present paper are taken from a previous study
(Sarasso et al., 2015). In the current study, ﬁfteen healthy participants (5
males, age 18–28 years) were randomly assigned to one of the three
experiments (N¼ 5 for propofol, xenon, and ketamine, respectively). All
participants gave written informed consent. The experimental protocol
was approved by the local ethical committee of the University of Liege
(Belgium). Before the experiment, medical history and physical exami-
nations were performed to exclude medical conditions that were
incompatible with anesthesia.
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All experimental procedures were performed at the Centre Hospitalier
Universitaire (CHU) in Liege, Belgium. Following drug administration,
repeated assessments of responsiveness were performed at 30-s intervals
using the Ramsay scale (Ramsay et al., 1974). Spontaneous EEG, fol-
lowed by TMS-EEG recording, was performed before drug administration
during the responsive wakefulness condition (Ramsay Scale score 2) as
well as upon reaching deep unresponsiveness in three consecutive as-
sessments (Ramsay Scale score 6, corresponding to no response to
external stimuli) (Ramsay et al., 1974). During wakefulness, eyes were
kept open (Weo) or closed (Wec) consistently with the anesthesia con-
dition: closed during xenon and propofol anesthesia, open during keta-
mine anesthesia. TMS-EEG procedures, pre-processing and analysis
(reported in (Sarasso et al., 2015)) yielded a single value for each
recording (PCI, see below).
At the end of the TMS-EEG recordings, anesthesia was discontinued,
participants were allowed to recover, and assessments of responsiveness
were continued every 30 s. In the event of nausea caused by the anes-
thetic drug, participants were given metoclopramide (2mg) to minimize
possible complications. In addition, participant's electrocardiogram, non-
invasive blood pressure, SaO2, exhaled CO2, and axillary skin tempera-
ture were continuously monitored.
2.3. ‘Conscious report’ and ‘no report’
In order to assess the presence/absence of conscious experience
during anesthesia-induced behavioural unresponsiveness, retrospective
reports were collected in all participants after awakening. For this pur-
pose, after participants recovered responsiveness (as assessed by three
consecutive Ramsey Scale score 2 evaluations), they were asked to report
their previous conscious experience (“what was going on through your
mind before awakening?”). Experience was deﬁned as “any kind of
mental activity,” which included thoughts, dreams, images, emotions,
etc. Responses were recorded and lumped into two categories: 1) ‘No
report’: this category included cases where no conscious experience was
reported, or no explicit recall was possible. One participant reported the
feeling of having felt something just prior awakening from Xenon anes-
thesia—thus several tens of minutes after the end of the resting-EEG
recording—but no explicit recall was possible; 2) ‘Conscious report’,
when the participant could describe the content of the experiences. Long,
vivid and emotionally intense experiences, with an explicit narrative
structure, were reported from all participants awakening from ketamine
anesthesia. An example report of ketamine-dreams can be found in
(Sarasso et al., 2015). While we cannot rule out that retrograde amnesia
or confabulation upon awakening affected reports, the collection of
retrospective reports remains the only available option to assess con-
sciousness beyond responsiveness. Dream reports are indeed commonly
employed to study mentation during sleep (Hobson et al., 2000; Siclari
et al., 2017).
2.4. Anesthetic procedures
Given that the depth of anesthesia is hard to compare when using
compounds acting on different molecular targets, the anesthetic pro-
cedures for the three experiments were aimed at reaching a common
behavioural state, i.e. unresponsiveness, systematically assessed by
means of repeated Ramsey Scale administrations. Thus, we attained
Ramsay Scale score 6 for all the subjects in the three experiments by
employing anesthetic procedures based on previous works. Speciﬁcally,
for propofol anesthesia see (Murphy et al., 2011), for xenon see (Rex
et al., 2006), while for ketamine we adopted induction procedures
similar to (Lee et al., 2013) and anesthesia maintenance following several
reports, as reviewed in (Miller et al., 2011).
Propofol. Propofol anesthesia was induced by a certiﬁed senior
anesthesiologist through an intravenous catheter placed into a vein of the633right hand or forearm. Throughout the study, the subjects breathed
spontaneously, and additional oxygen (5 L/min) was given through a
loosely ﬁtting plastic face mask. Anesthesia was obtained with a target-
controlled infusion (Alaris TIVA; CareFusion). The pump was
controlled by a software algorithm based on the Marsh adult pharma-
cokinetic model for propofol (Marsh et al., 1991) set at 3 μg/ml. When
the appropriate effect site concentration was reached, a 5-min equili-
bration period was allowed to ensure equilibration of propofol reparti-
tion between compartments.
Xenon. Xenon anesthesia was induced by a certiﬁed senior anesthe-
siologist. Before xenon administration, we performed a denitrogenation
with 100% oxygen applied via a facial mask. Once completed, a 2–3mg/
kg bolus of propofol was administered through a right arm or forearm
intravenous catheter in order to allow the insertion of a laryngeal mask
securing the airway. Xenon was then introduced progressively and pro-
pofol was withdrawn. We then waited for spontaneous reduction of
plasmatic propofol concentration (propofol washout) until calculated
propofol plasma concentration were below 1 μg/ml (Rex et al., 2006),
within a subanesthetic range (Fiset et al., 1999) after which anesthesia
was maintained with xenon (62.5 2.5% in oxygen) using a Dr€ager
PhysioFlex closed circuit ventilator (Dr€ager; Luebeck, Germany). Par-
ticipants were undergoing assisted spontaneous ventilation with pressure
control maintaining normocapnia and received a total amount of xenon
ranging from 24 to 32 L.
Ketamine. Ketamine anesthesia was induced by a certiﬁed senior
anesthesiologist using a 2mg/kg intravenous infusion (diluted in 10mL
of 0.9% normal saline) of racemic ketamine (Ketalar®, Pﬁzer Ltd, Istan-
bul, Turkey) over 2min and maintained by continuous ketamine infusion
at 0.05mg/kg/min (Baxter infusion pump AS40A; Baxter Healthcare
Corp., Deerﬁeld, IL) over the entire experimental procedures.
2.5. EEG acquisition and preprocessing
EEGmeasurements were performed using a 60-channel EEG ampliﬁer
(Nexstim Plc., Finland). EEG signals were referenced to an additional
electrode on the forehead, online ﬁltered (0.1–350Hz) and sampled at
1450Hz. Two extra sensors were used to record the electrooculogram.
Impedance at all electrodes was kept below 5 kΩ. Raw EEG signals are
made available online upon request, at the repository Zenodo (https://
doi.org/10.5281/zenodo.806176). EEG signals were ofﬂine ﬁltered in
forward and reverse direction with a high-pass (cutoff: 0.5 Hz) and a low-
pass (cutoff: 60 Hz) 5th order Butterworth IIR ﬁlter. Supplementary
analysis was performed without any additional temporal ﬁlters (see
Supplementary Material, section 1), in order to consider frequencies
below 1Hz. Bad channels were rejected based on visual inspection
(10% of channels per recording). Rejected channels were then inter-
polated using spherical splines. Continuous data was segmented (2 s
length) and artifactual epochs were rejected following visual inspection.
In addition, to minimize the inﬂuence of electromyographic (EMG) and
electrooculographic (EOG) activity, ICA decomposition was performed;
components were visually inspected with respect to their topography,
their time-series and their PSD. ICA components resembling EMG activity
(large high-frequency power relative to low frequency power, highly
localized scalp-origin—i.e. high spatial kurtosis—and EMG-like temporal
structure—i.e. spiking activity), as well as those resembling EOG activity
(temporally sparse and sharp activation, pre-frontal topography and
either symmetric or asymmetric polarity, corresponding to blinks or eye
movements) were identiﬁed. Artifactual components were removed
(xenon: mean std, 7.20 3,19; propofol: 8.40 3.36; ketamine:
22.6 8.62; Wakefulness with eyes open: 21.60 7.76; Wakefulness
with eyes closed: 19.70 5.06), and the residual components were back-
projected to the electrode space. Only the ﬁrst 5 min of available clean
data were considered for further analysis.
Besides the manual cleaning procedure described above, we per-
formed in parallel an automated-cleaning procedure, in order to assess
the feasibility of a fully-automated processing pipe-line yielding the
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main text, and replicated the results (See Supplementary Material, sec-
tion 2).
2.6. Estimation of the spectral exponent from the PSD background
The power spectral density (PSD) was estimated at each electrode
(see topographies in Supplementary Fig. 5) using the Welch's method,
with a Hanning windows of 2 s and 50% overlap. The linear trend within
each window was removed prior to spectral estimation, to avoid the bias
due to low frequencies outside the frequency range under scrutiny.
The PSD background (i.e. non-oscillatory) decays approximately ac-
cording to an inverse power-law: PSD(f) ~ 1/f α (Pritchard, 1992); here
we report the spectral exponent β¼ - α. The spectral exponent is thus
equivalent to the slope of a linear regression of the PSD, ﬁt after taking
the logarithm of both the x and y axis. However, when linearly-spaced
frequency bins are considered under a logarithmic scale, bins in
higher-frequencies become progressively more dense, and thus gain
disproportionate weight with respect to lower frequency-bins in a sub-
sequent linear regression (Hwa and Ferree, 2002). To avoid this potential
bias, we up-sampled the PSD curve with logarithmically spaced fre-
quency bins (such that the upsampled PSD had 4 times the number of
datapoints than the original PSD), resulting in equally-spaced frequency
bins under logarithmic scale, required to properly estimate the spectral
exponent.
To intuitively illustrate how changes in the spectral exponent relate to
changes in the temporal properties (‘smoothing’ and ‘slowing’) of the
EEG, an EEG signal recorded during wakefulness is ﬁltered so as to obtain
progressively more negative spectral exponents (Fig. 1). Filtering con-
sisted in taking the Fourier transform of the signal, changing the slope of
the PSD (PSD rotation), then reconstructing the signal via the inverse
Fourier transform. Here, PSD rotation was obtained by multiplying the
PSD by 1/f β, with β spanning from 0 to 1 (green to black signal in Fig. 1),
then dividing the PSD by its mean.
The exact peak frequency of the oscillations can vary across in-
dividuals, and the bandwidth can change across the scalp (Klimesch
et al., 2007). For this reason, rather than deﬁning a priori the frequency
bands that deviate from a power-law behaviour, we deﬁned these bands
following a data-driven procedure. A three-step procedure was
conceived in order to estimate the spectral exponent β of the background
PSD, while discarding frequencies exhibiting oscillatory peaks. 1) A ﬁrst
least-square line was ﬁt to the PSD, under double-logarithmic axis. 2)
Frequency bins with large positive residuals (larger than 1 median634absolute deviations of the residual distribution) were considered as likely
containing oscillatory peaks. The contiguous frequency bins with positive
residuals were considered as part of the base of the peak, and thus
removed from subsequent analysis. 3) A second least-square line was
then ﬁt on the remaining frequency bins (i.e. those consistent with a
power-law behaviour). The slope of this second line corresponded to the
spectral exponent β of the PSD background (Fig. 2). The spectral expo-
nent at each electrode was relatively homogenous across the scalp within
conditions (Supplementary Fig. 5). In order to obtain a single estimate of
the spectral exponent across the scalp, the average spectral exponent
across electrodes was considered for each participant for all subsequent
analysis. The Matlab code to estimate the spectral exponent is available
online: https://github.com/milecombo/spectralExponent/blob/master/
README.md.
We corroborated the proposed three-step procedure by performing
supplementary analysis with a previously published method—Irregularly
Resampled AutoSpectral Analysis (IRASA)—aimed at isolating the fractal
(non-oscillatory) component of the PSD (Wen and Liu, 2016). The two
procedures yielded highly similar spectral exponents (Supplementary
Material, section 1; Supplementary Fig. 2).
2.7. Broad-band spectral exponent
Using this method, we ﬁrst estimated the overall spectral exponent for
a broad frequency range (1–40 Hz) (Fig. 2A). We avoided to ﬁt the slope
for frequencies below 1Hz, due to the sensitivity of the EEG at these
frequencies to slow-drifts of the signal, movement artifacts and high-pass
ﬁlter-attenuations. Accordingly, we set a high-pass ﬁlter cutoff at 0.5 Hz.
We also avoided to ﬁt the slope for frequencies above 40 Hz due to the
sensitivity of the EEG at these frequencies to potential muscle arti-
facts—although these were already minimized by the ICA cleaning (see
Method, section 2.5).
2.8. Sub-bands: low-band and high-band spectral exponent
A subsequent closer examination of the PSD decay revealed a ‘knee’ at
~20Hz (evident in Figs. 2 and 3A). In order to obtain a better local ﬁt, we
therefore split the broad 1–40Hz band in two equally spanning sub-
bands for additional analysis, obtaining a ‘low-band’ (1–20 Hz,
Fig. 2B), and a ‘high-band’ (20–40 Hz, Fig. 2C). For all conditions of
wakefulness (N ¼ 15), the low frequency range displayed a ﬂatter slope
with respect to the high frequency range: mean  std, 0.80  0.29 and
2.55  0.93 respectively, T(14) ¼ 5.78, P ¼ 4*105. These two sub-Fig. 1. A more negative broad-band spectral
exponent (β) indexes a steeper power spectral
density (PSD) decay, related to a ‘slower’ and
‘smoother’ temporal proﬁle of the EEG signal. As β
decreases, the amplitude of high frequencies becomes
smaller relative to the amplitude of low frequencies
(‘EEG slowing’). To illustrate this concept, an EEG
signal (recorded during wakefulness, green) is pro-
gressively ﬁltered, so as to reduce its broad-band
spectral exponent (darker colors). Filtering is ob-
tained by taking the Fourier transform of the original
signal, changing the slope of the PSD (PSD rotation),
then reconstructing the signal via the inverse Fourier
transform. The temporal proﬁle of each signal is
shown on the left panel (only 10 s out of 5 min are
shown); the relative PSD, estimated with the Welch's
method, is shown on the right panel. Note the
appearance of slow waves and the reduction of high-
frequency activity—typical signatures of the loss of
consciousness during general anesthesia—as the PSD
becomes progressively steeper.
Fig. 2. The background of the Power Spectral
Density of the EEG decays according to an inverse
power-law: PSD(f) ~1/fα, with β¼ -α. The spectral
exponent β indexes the steepness of the decay of the
PSD background. Oscillations (Theta, Alpha, Beta)
appear as peaks above the Power Spectral Density
(PSD) background, and thus deviate from the overall
1/f shape. A three-step ﬁtting procedure is devised to
discard oscillatory peaks, prior estimating the back-
ground slope. Fitting is done separately for three fre-
quency ranges: broad-band (1–40 Hz, A), low-band
(1–20 Hz, B, left) and high-band (20–40 Hz, B, right).
1) Fit a ﬁrst OLS line to the PSD (gray dashed line), in
log-log coordinates. 2) Identify and discard frequency
bins around oscillatory peaks (bins with large positive
residuals, >1 median absolute deviation). Adjacent
bins with positive residuals are also discarded, so as to
discard both the top and the base of the peak (thin
blue dotted line). 3) Fit a second OLS line (thick black
line) to the remaining frequency bins. The slope of
this second line corresponds to the spectral exponent.
Fig. 3. The background of the PSD decays differ-
ently across conditions. EEG was recorded during
wakefulness and anesthesia in three groups of healthy
participants, undergoing a speciﬁc anesthetic pro-
cedure; either: xenon (black) propofol (blue) or keta-
mine (red). During wakefulness, participants had their
eyes open (light-green) or closed (dark-green)
consistently with the anesthesia condition (open prior
Ketamine, closed prior Xenon or Propofol). Each line
shows the grand-average PSD across participants; the
shaded area indicates the bootstrapped 95% conﬁ-
dence interval for the mean across participants. Fre-
quency bins around oscillatory peaks (dotted line)
deviate from the background power-law decay (solid
line) of the grand-average PSD. We assessed whether
frequency bins adhered or deviated from the back-
ground power-law trend, separately for the broad-
band (1–40 Hz, A), for the low-band (1–20 Hz, B),
and for the high-band (20–40 Hz, C). Note that in the
main analysis, deviations from power-law behaviour
were assessed for each participant at the single elec-
trode level.
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nipulations, as detailed in the Results, section 3 and in Fig. 3. The PSD
and the frequency bins adhering to an inverse power-law behaviour are
displayed for the grand-average across participants, in each experimental
condition (Fig. 3A, B, C, respectively for the broad-band, the low-band
and the high-band). As explained before, in the main analysis, the devi-
ation from power-law behaviour at each frequency bin was assessed for
each participant at the single electrode level. Nonetheless, deviations
appeared at similar frequencies across electrodes and participants (Sup-
plementary Material, section 3-5; Supplementary Figs. 6 and 7; Supple-
mentary Table 1).
2.9. Repeated-measures ANOVA: speciﬁc effects of the anesthetics
In order to estimate the effect of each anesthetic on the spectral
exponent, we conducted a repeated-measures ANOVA, for each fre-
quency band (broad-band, low-band, high-band). The models had anes-
thetic (xenon, propofol, ketamine) as between-subject factor, and
condition (wakefulness, anesthesia) as within-subject factor. To observe
whether each anesthetic induced a consistent change across all the
members of the group, we visualized the spectral exponents during635wakefulness and anesthesia for each participant (Fig. 4A). For each
frequency-band and anesthetic, we performed planned paired t-tests to
contrast conditions (Table 1); p-values were accordingly corrected with
the FDR procedure across bands and anesthetics.
2.10. Discriminant analysis: ‘conscious report’ vs ‘no report’
Besides this, we were interested in determining how well the spectral
exponent could discriminate states with conscious report from states
where report was absent. The outcomes of the ANOVA analysis were not
used to perform feature-selection, thereby we could perform a classiﬁ-
cation analysis on the same dataset—using a cross-validation sche-
me—without incurring in overﬁtting problems. The classes to be
discriminated (‘Conscious report’, ‘No report’) were formed based upon
subjective reports performed immediately during wakefulness or delayed
upon awakenings from anesthesia (see section 2.3, as well as (Sarasso
et al., 2015)). We therefore pooled all the EEG recordings of the xenon
and propofol condition in the ’No report’ class (N¼ 10), and all the EEG
recordings during the wakefulness condition (irrespectively with eyes
open, Weo, or eyes closed, Wec) and ketamine condition in the
‘Conscious report’ class (N¼ 20). We performed a linear discriminant
Fig. 4. The spectral exponent reliably sepa-
rates conditions where a conscious report
could be obtained (wakefulness, ketamine)
from conditions where no report could be
obtained (xenon, propofol). Reports were
assessed immediately (wakefulness) or upon
recovery from unresponsiveness (anesthesia). A)
The broad-band spectral exponent in the ‘No
report’ class (xenon, propofol) decreases
dramatically with respect to the ‘Conscious
report’ class (wakefulness, ketamine), indexing
a steeper decay of the background of the PSD.
Boxplots and individual values of the spectral
exponent are shown for each condition: wake-
fulness with eyes closed (Wec, dark-green),
wakefulness with eyes open (Weo, light-green),
xenon (X, black), propofol (P, blue), ketamine
(R, red). Datapoints belonging to the same
participant are connected by a dotted line. B)
Considering the spectral exponent jointly over
the low-band (1–20 Hz) and the high-band
(20–40 Hz), reveals distinct regions for the ‘No
report’ and the ‘Conscious report’ classes, as
well as for each anesthetic-drug. Marginal plots,
bottom and left, display for each participant the
values of the spectral exponent in the low-band
(1–20 Hz) and in the high-band (20–40 Hz)
respectively. These values are displayed
together as a joint distribution in the central
plot, revealing that the two bands are negatively
correlated within the ‘Conscious report’ and the
‘No report’ class. Ellipses represent the central
95% of a normal bivariate distribution, ﬁtted to
the data. The ellipse of the ‘No report’ class (X,
P, black shaded area) does not overlap with that
of the ‘Conscious report’ class (Wec, Weo, K,
green shaded area).
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Table 1
Spectral scaling exponents (β), estimated as the slope of the background of the PSD under log-log coordinates, after discarding peaks. The mean spectral
exponent across electrodes was considered for each participant; condition-averages are reported below. P-values for the contrasts are reported both as raw uncorrected
values (P-raw, in gray), and after the correction with the False Discovery Rate (FDR) procedure across anesthetics and frequency bands (P-FDR). Bold and italics
respectively highlight signiﬁcant (P< 0.05) and trend-level (P< 0.1) FDR-corrected P-values.
Spectral exponent β
Condition Anesthesia (mean std) Wakefulness (mean std) Contrast Anesthesia vs Wakefulness
T (df¼ 4) (P-raw) P-FDR
Broad-Band (1–40 Hz)
Xenon 2.63 0.33 1.10 0.33 12.11 (0.0003) 0.0006
Propofol 2.11 0.11 1.01 0.14 12.31 (0.0003) 0.0006
Ketamine 1.40 0.32 1.06 0.14 2.13 (0.1006) 0.1006
Low-Band (1–20 Hz)
Xenon 2.36 0.51 0.92 0.41 13.01 (0.0002) 0.0006
Propofol 1.68 0.12 0.66 0.16 14.15 (0.0001) 0.0006
Ketamine 1.40 0.43 0.82 0.26 2.55 (0.0632) 0.0711
High-Band (20–40 Hz)
Xenon 3.59 1.23 2.03 1.05 3.62 (0.0224) 0.0336
Propofol 4.36 0.92 3.13 0.47 2.84 (0.0467) 0.0600
Ketamine 0.08 0.50 2.48 0. 97 5.38 (0.0058) 0.0104
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the accuracy, sensitivity, speciﬁcity, and area under the ROC curve
(AUC-ROC) of the spectral exponent features in discriminating the
‘Conscious report’ class from the ‘No report’ class. We evaluated the
performance of a single-feature classiﬁer (broad-band spectral exponent)
and a two-features classiﬁer (the low-band and the high-band spectral
exponents). We evaluated the degree of separation between classes ob-
tained with the single-feature classiﬁer vs the two-features classiﬁer, by
comparing the mean silhouette values (based upon Euclidean distances),
and the t-values relative to the contrast of the two classes. These two
statistics allowed to estimate which classiﬁer was better, even when both
classiﬁers had 100% accuracy. Furthermore, we characterized the spread
of the datapoints within each class along the two largest directions of
variation within the two-dimensional space of the two features (Fig. 4B).
For this purpose, we plotted an ellipse centered in the centroid of the two
features, oriented along the two principal directions of variation (ei-
genvectors), and whose width was set as the 5th and 95th percentile of a
normal bivariate distribution with the mean and variance estimated from
the observed data points. This procedure allowed us to visually appre-
ciate if there was any signiﬁcant overlap between the regions belonging
to each class. We also computed the correlation coefﬁcient within each
class between the high and low frequency spectral exponent, in order to
characterize their mutual relationship. To quantify the overlap between
the two classes, we reported how many individual recordings occupied
values more extreme (in the direction of the difference of the means of
each condition) than the range of values occupied by the other condition
of interest.2.11. Supplementary discriminant analysis: ketamine vs wakefulness and
xenon vs propofol
As a secondary aim, we furthermore evaluated the performance of the
classiﬁers, with a single or with two-features, to discriminate speciﬁc
conditions characterized by either the presence of reports—i.e. ketamine
vs wakefulness—or the absence of retrospective reports—i.e. xenon vs
propofol (see results in Supplementary Material, section 6).2.12. Correlations of the spectral exponent with the perturbational
complexity index
We furthermore assessed the relationship between two different
neurophysiological markers of the level of consciousness, both inde-
pendent from behavioural responsiveness. In order to do this, we
computed the correlation across all individual recordings between the
spectral exponent—based upon spontaneous EEG—and the Perturbation637Complexity Index (PCI) —based upon the EEG response to TMS derived
by a previous study (Sarasso et al., 2015). In brief, PCI gauges the amount
of information contained in the integrated response to a direct
perturbation—i.e. the spatiotemporal patterns of TMS-evoked cortical
source activity. Speciﬁcally, PCI is calculated as the Lempel-Ziv
complexity (cL) of the binarized activity sequence of length L, normal-
ized by the corresponding source entropy H(L). PCI is thus computed as:
PCI ¼ cLlog2L = LHðLÞ (Casali et al., 2013).
3. Results
3.1. Repeated-measures ANOVA: speciﬁc effects of the anesthetics
The effect of the three anesthetics (xenon, propofol, ketamine) on the
spectral exponent β was assessed by means of a repeated-measures
ANOVA test, separately for the three frequency bands (broad-band,
low-band and high-band). Planned t-contrasts of condition (wakefulness
vs anesthesia) for each anesthetic were performed applying the False
Discovery Rate (FDR) procedure to the resulting P-values, across anes-
thetics and across the three frequency bands (Table 1). For the broad-
band spectral exponent, we observed a main effect of condition
(F(1,12) ¼ 180.64, P ¼ 1*108) and anesthesia-type (F(2,12) ¼ 11.76,
P ¼ 0.0015), and a signiﬁcant interaction effect (F(2,12) ¼ 22.60,
P ¼ 9*105). As compared to the wakefulness condition of each partic-
ipant, the broad-band spectral exponent was reduced (indexing a steeper
PSD decay) to a large extent during xenon and to a lesser extent during
propofol, while it did not signiﬁcantly change during ketamine (Figs. 3A
and 4A, Table 1).
Results obtained for the low-band spectral exponent resembled those
of the broad-band. Also in this case, we observed a main effect of con-
dition (F(1,12) ¼ 136.14, P ¼ 7*108) and anesthetic (F(2,12)¼ 4.52,
P¼ 0.0343), and a signiﬁcant interaction effect (F(2,12)¼ 8.42,
P¼ 0.0052). Again, as compared to the wakefulness condition of each
participant, the low-band spectral exponent was reduced to a large extent
during xenon, to a lesser extent during propofol, while it did not signif-
icantly change during ketamine (Figs. 3B and 4B, Table 1).
On the other hand, for the high-band spectral exponent, we did not
observe a main effect of condition (F(1,12)¼ 0.26, P¼ 0.6177), while we
did observe an effect of anesthetic (F(2,12)¼ 13.54, P¼ 8*104), as well
as a signiﬁcant interaction effect (F(2,12) ¼ 25.29, P ¼ 5*105). Spe-
ciﬁcally, as compared to the wakefulness condition of each participant,
the high-band spectral exponent decreased in xenon and in propofol,
while it increased in ketamine (Figs. 3C and 4B, Table 1).
In sum, xenon and propofol largely decreased the spectral exponent
across the two sub-bands in all participants; such decrease was therefore
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the spectral exponent in the two sub-bands—decreasing it in the low-
frequency band (albeit only at trend-level) and increasing it in the
high-frequency band. Notably, these two opposite changes yielded a
broad-band spectral exponent that was overall similar to that observed
during wakefulness (Figs. 3A and 4A).3.2. Discriminant analysis: ‘conscious report’ vs ‘no report’
For the main aim, we discriminated conscious states from states
where consciousness was greatly reduced or absent, based on the EEG
spectral exponent features. We hereby consider the average performance
across partitions in discriminating the ‘Conscious report’ class (wake-
fulness, ketamine) from the ‘No report’ class (xenon, propofol), for the
single-feature (broad-band spectral exponent) and the two-features
classiﬁer (low- and high-band spectral exponents). The single-feature
classiﬁer, yielded 100% accuracy, sensitivity and speciﬁcity, and the
area under the receiver operating characteristic curve (AUC-ROC) was
equal to 1. Similarly, the classiﬁer with two-features, yielded 100% ac-
curacy, sensitivity and speciﬁcity, and the AUC-ROC was equal to 1. A
larger distance between ‘Conscious report’ and ‘No Report’ class could be
observed when considering two features jointly (Fig. 4B) as compared to
when using a single feature (Fig. 4A), as indexed by a larger silhouette
value (0.7930 vs 0.6836), and by a larger t-value (13.22 vs 10.16
respectively).
We then considered the overlap between the spectral exponent values
of these two classes, reporting how many individual recordings occupied
values that were more extreme (in the direction of the difference of the
means of each condition) than the range of values occupied by the other
condition of interest. The spectral exponent in the 1–40Hz of the ‘No
report’ class (N¼ 10), as compared to the ‘Conscious report’ class
(N¼ 15), was largely more negative (β, mean std, ‘No report’:
2.37 0.35; ‘Conscious report’: 1.14 0.28) in all 10 recordings
(Fig. 4A). Furthermore, the spectral exponent of the ‘No report’ class was
more negative (‘No report’: 2.02 0.50; ‘Conscious report’:
0.95 0.41) in 3 recordings for the 1–20Hz, while it was more nega-
tive (‘No report’: 3.97 1.10; ‘Conscious report’: 1.93 1.38) in 6
recordings for the 20–40 Hz (Fig. 4B).
There was a negative correlation between the low and high spectral
exponents in the ‘Conscious report’ condition (R ¼ 0.85, P ¼ 2*106)638and, although only at trend-level, in the ‘No report’ class (R¼0.61,
P¼ 0.0608). Consistently, the main direction of variance was similar for
both the ‘Conscious report’ and the ‘No report’ class, as depicted by the
ellipses in Fig. 4. The data-points of the two classes occupied separate
regions in the two-dimensional space formed by the two features.
Furthermore, there was no overlap between the ellipses of the two
classes, each covering the central 95% of a normal distribution with
mean and standard deviation estimated from the datapoints of each class.
3.3. Supplementary discriminant analysis: ketamine vs wakefulness and
xenon vs propofol
After discriminating the ‘Conscious report’ from the ‘No report’ class,
we tested the ability of the spectral exponent β to discriminate speciﬁc
conditions within each class characterized by either the presence of
reports—i.e. ketamine vs wakefulness—or the absence of retrospective
reports—i.e. xenon vs propofol. Results are detailed in the Supplemen-
tary Material, section 6). In sum, the broad-band spectral exponent did
not distinguish ketamine anesthesia from resting wakefulness (Fig. 4A).
When the low- and high-band spectral exponents were jointly considered
(Fig. 4B), ketamine could be distinguished from resting wakefulness, due
to a spectral exponent that was largely overlapping in the 1–20 Hz range
and smaller in the 20–40Hz range. Furthermore, xenon could be partially
distinguished from propofol by a steeper spectral exponent both in the
1–20 Hz as well as in the 1–40 Hz range (Fig. 4).
3.4. Correlation of the spectral exponent with the perturbational
complexity index
Finally, we assessed the overall correlation between the spectral
exponent and an established measure of the level of conscious-
ness—perturbational complexity index, PCI— derived from the EEG re-
sponses to TMS (Fig. 5). PCI was highly correlated with the spectral
exponent across all recording sessions, most prominently for the broad-
band (R ¼ 0.86, P-raw ¼ 1*109, P-corrected ¼ 3*109), as well as for
the low-band (R¼ 0.76, P-raw¼ 1*106, P-corrected¼ 2*106) and less
so (although signiﬁcantly) for the high-band (R¼ 0.51, P-raw¼ 0.0041,
P-corrected¼ 0.0041). Thus, even though the correlation of PCI with the
20–40Hz spectral exponent was smaller than that with the 1–20 Hz
spectral exponent, PCI correlated themost with the spectral exponent of aFig. 5. The spectral exponent at rest is robustly
correlated to the complexity of the TMS-evoked
response, as assessed by Perturbation Complexity
Index (PCI).PCI is an empirical measure that is
maximized by the joint presence of integration and
differentiation, a fundamental requirement for the
emergence of consciousness. Both PCI and the spectral
exponent peaked for the ‘Conscious report’ class
(wakefulness, dark and light green dots; ketamine
anesthesia, red dots) and were the lowest for the ‘No
report’ class (propofol anesthesia, blue dots; xenon
anesthesia, black dots). Although PCI correlated better
with the low-band exponent (1–20 Hz, B) than with
the high-band exponent (20–40 Hz, C), the best cor-
relation is obtained with the broad-band exponent
(1–40 Hz, A), suggesting that PCI is related to the
scaling properties of a broad range of frequencies. A
linear-ﬁt across all datapoints is shown as a dotted
line. Ellipses represent the central 95% of a normal
bivariate distribution, ﬁtted to the data. The orienta-
tion of the ellipses reveal the direction of largest
variation of the data-points within each class.
M.A. Colombo et al. NeuroImage 189 (2019) 631–644broad 1–40Hz band, encompassing both the low- and high-band.
4. Discussion
In the present work, we aimed to assess how anesthesia, induced by
three anesthetics with distinct mechanisms of action, changed the overall
decaying shape of the PSD of the resting EEG. Speciﬁcally, the steepness
of the PSD decay was indexed by the spectral exponent β, once spectral
peaks were removed. Furthermore, based on β, we aimed to objectively
discriminate states in which conscious experience occurs—‘Conscious
report’—such as during wakefulness or ketamine anesthesia, from states
in which consciousness is greatly reduced or absent—‘No report’—such
as during xenon or propofol anesthesia. Participants regaining respon-
siveness from either propofol or xenon anesthesia did not report any
conscious experience during the unresponsive period. However, partici-
pants regaining responsiveness from ketamine anesthesia conﬁrmed
having had conscious experience, reporting long and vivid dream-like
psychedelic experiences while disconnected from the external environ-
ment, in line with previous subjective reports (Bowdle et al., 1998;
Brown et al., 2011; Gouzoulis-Mayfrank et al., 2005; Kiefer et al., 2008).
During wakefulness, the PSD of the resting EEG decayed approximately
as f β (β~ -1) over a broad frequency range, consistently with previous
EEG observations (Dehghani et al., 2010; Pereda et al., 1998; Susmakova,
2006). The broad-band spectral exponent remained approximately un-
changed during ketamine anesthesia, consistent with the presence of
conscious reports. On the other hand, the absence of conscious reports
following both xenon and propofol anesthesia was associated with a
sharp decrease of the broad-band spectral exponent in all participants,
indexing a steeper PSD decay (Figs. 3A and 4A).
4.1. PSD decay and activity propagation
A steepening of the PSD was previously observed, among other re-
sults, in a computational model of general anesthesia, due to the
blockade of network activity propagation (Zhou et al., 2015). A single
parameter controlled the probability of percolation of stochastic activity
through a hierarchical network. Below a certain probability threshold,
the network-activity underwent a sharp transition, which resembled the
rapid loss of consciousness occurring within a narrow anesthetic con-
centration. Indeed, the simulated EEG rapidly slowed, becoming more
regular, and the PSD steepened. Accordingly, a steepening of the PSD, as
measured by a more negative spectral exponent, was also associated with
reduced entropy at short-time scales across the wake/sleep cycle (Mis-
kovic et al., 2018). Reduced entropy at short-time-scale indexes more
regular local brain dynamics, underpinned by increased synchronization
of neuronal assemblies.
The scaling of the PSD could be explained by mechanisms based upon
stochastic activity and different ﬁltering properties of extracellular media
(Bedard et al., 2006). Alternative proposals provide a functional expla-
nation for 1/f behaviour and the steepening of the PSD. Speciﬁcally, the
steepening of the PSD could result from the dampening of activity
propagation mediated by refractory periods, as modelled in a simulated
network with only excitatory neurons (Freeman and Zhai, 2009).
Recently, a more realistic model, including both excitatory and
inhibitory populations, further pointed to the crucial role of blocking
activity propagation in steepening the PSD decay (Gao et al., 2017). In
this case, a network simulating LFP activity received stochastic inputs
from both an excitatory and an inhibitory population, each with a
particular conductance proﬁle. The current ﬂuctuations of the input from
the inhibitory population, compared to those from the excitatory popu-
lation, had a steeper PSD-decay. Thus, when increasing the contribution
of the inhibitory population, relative to that of the excitatory one—i.e. by
reducing the excitation/inhibition (E/I) ratio—the PSD of the
simulated-LFP also steepened its decay. This prediction was veriﬁed in
different experimental set-ups, within the same study (Gao et al., 2017).
Indeed, the E/I balance modiﬁed the PSD-slope in LFP recordings in the639rat hippocampus, when considering temporal excitability ﬂuctuations
driven by theta-cycle, as well as spatial changes in inhibitory synaptic
density. Furthermore the PSD of macaque ECoG became steeper during
propofol-induced loss of consciousness—as here reported—and its tem-
poral changes well matched the time-course of anesthetic action. This
study therefore provides a mechanistic explanation for changes in the
spectral exponent across the induction of- and recovery from-anesthesia,
in terms of global changes in the balance between excitation and
inhibition.
Furthermore, as during physiological sleep the E/I balance shifts to-
wards inhibition, EEG activity is characterized by a steeper PSD decay
over a broad range of frequencies (Miskovic et al., 2018; He et al., 2010;
Freeman and Zhai, 2009; Pereda et al., 1998; Freeman, 2006;
Susmakova, 2006). In sum, pharmacological, physiological as well as
computational evidence show that changes in the E/I balance result in
changes in the spectral exponent, estimated over a broad range of fre-
quencies, encompassing those under scrutiny in the current study.
4.2. Activity propagation, E/I balance and the capacity for consciousness
Multiple empirical observations indicate that a marked alteration of
neuronal activity propagation, mainly regulated by the E/I balance, could
impede the emergence of consciousness. On the one hand, low E/I may
lead to unconsciousness—as in barbiturate anesthesia (Scott et al., 2014),
propofol anesthesia (Solovey et al., 2015; Tagliazucchi et al., 2016), or
deep sleep (Kantelhardt et al., 2015; Meisel et al., 2017; Tagliazucchi
et al., 2013; Priesemann et al., 2013). On the other hand, high E/I may
also lead to unconsciousness, as during epileptic seizures (Meisel et al.,
2012; DiNuzzo et al., 2014) and during xenon anesthesia (Hirota, 2006).
In either case, states where consciousness is greatly impaired or abol-
ished are characterized by rather excessive or insufﬁcient propagation of
activity (Tagliazucchi, 2017). Consistently, in our study, both xenon and
propofol anesthesia markedly reduced or abolished conscious
experience.
Conversely, the waking brain normally operates in a state where ac-
tivity is at the edge of extinction, such that the propagation of activity is
approximately balanced, yet slightly over-compensated by dampening
mechanisms, i.e. slightly skewed towards inhibition. This idea is sup-
ported by theoretical work (Carhart-Harris et al., 2014; Pearlmutter and
Houghton, 2009), and by multiple lines of experimental evidence (Prie-
semann et al., 2014; Hahn et al., 2017). Therefore, there is room for an
increase in excitation—such as that induced by glutamate release
mediated by classical psychedelic drugs, e.g. LSD, and dissociative an-
esthetics, e.g. Ketamine (Preller and Vollenweider, 2018)—while keep-
ing the E/I still approximately balanced, and preserving the capacity for
consciousness (Carhart-Harris et al., 2014). Consistently, in our study,
ketamine, even at anesthetic doses, preserved the capacity for
consciousness.
We now consider in depth the relationship between changes in the
spectral exponent and the speciﬁc mechanism of action of each
anesthetic.
4.3. Spectral exponent and mechanisms of action: propofol
In the current study, propofol induced a prominent slowing of the
EEG across the 1–40Hz range, as indexed by a more negative spectral
exponent in the broad-band, as well as in both the low and high fre-
quency bands (Figs. 3 and 4, Table 1). The induction of a prominent alpha
oscillation (Fig. 3A, Supplementary Figs. 6 and 7) is well documented in
previous work on propofol anesthesia (Purdon et al., 2015; Murphy et al.,
2011; Scheinin et al., 2018a); yet, very few studies investigated the
behaviour of EEG arrhythmic activity. Speciﬁcally, in a study of the
human ECoG, the PSD showed a steeper decay across a broad frequency
range in the four patients under propofol anesthesia, as compared to the
one awake patient (Fig. 2 in Freeman et al., 2000) (Freeman et al., 2000).
Furthermore, a bolus injection of propofol resulted in temporary
M.A. Colombo et al. NeuroImage 189 (2019) 631–644widespread decreases of the spectral exponent of the ECoG in macaques,
with a time of onset and recovery time consistent with the loss and re-
covery of consciousness (Gao et al., 2017). Consistently, tiagabanine, an
anesthetic with similar mechanism of action (GABA-a potentiation),
increased the spectral exponent in human ECoG over a broad frequency
range (5–100Hz) (Muthukumaraswamy and Liley, 2018). Thus,
propofol-induced large inhibition—mediated by GABA-A potentiation
(Brown et al., 2011; Franks, 2008)—results in activity dampening
(Solovey et al., 2015; Tagliazucchi et al., 2016) and in a steeper PSD
decay—as indexed by a more negative spectral exponent (Gao et al.,
2017).
4.4. Spectral exponent and mechanisms of action: xenon
Similarly to propofol, xenon yielded an overall slowing of the EEG
across the 1–40 Hz range, as reﬂected by a decreased spectral exponent in
the broad-band, as well as in the low and high frequency bands. This is
consistent with previous literature, where xenon decreased the 95%
spectral edge frequency (Goto et al., 2000; Laitio et al., 2008)—indexing
an overall slowing of EEG activity—and largely increased low-frequency
activity, in the delta and theta range (Laitio et al., 2008). Furthermore,
xenon induced changes in the PSD that became progressively smaller as
the frequency band increased from delta to beta—as expected when the
overall PSD background becomes steeper (Laitio et al., 2008).
Contrarily to most anesthetics, xenon has little or no effect on GABA-A
receptors (Franks et al., 1998). One of the proposedmechanisms of action
of xenon is the potent non-competitive inhibition of N-methyl--
D-aspartate (NMDA) receptors (Franks et al., 1998). Paradoxically, the
antagonism of xenon on NMDA receptors may lead to over-excitation of
cerebral wakefulness-promoting neurons—as indexed by increased
norepinephrine and acetylcholine release—and thereby to loss of con-
sciousness (Hirota, 2006).
Such over-excitation may seem at odd with the observed steepening
of the PSD, according to previous hypothesis and simulation (Gao et al.,
2017). However, this contradiction is only apparent. In this simulation
(Gao et al., 2017), lowering the E/I ratio (from 1:2 to 1:6) towards deep
inhibition resulted in a steeper PSD. Yet, in another simulation (Lombardi
et al., 2017), a steeper PSD resulted from increasing the E/I ratio (from
~1:0.4 to 1:0) towards deep excitation. The latter situation seems more
appropriate for xenon anesthesia. Future modelling studies should try to
integrate these ﬁndings, by covering a wide range of E/I and verifying
whether indeed the spectral exponent decreases in either states of deep
inhibition and excitation.
Besides its antagonizing action on NMDA receptors, xenon acts pri-
marily on two-pore-domain Kþ (2 PKþ) channels, strongly potentiating
2 PKþ conductance (Franks, 2008). Hence, xenon reduces the inﬂuence
of excitatory currents (neuronal disfacilitation) thus possibly engen-
dering a state of neuronal bistability (Timofeev et al., 2001). Neuronal
bistability reﬂects an intrinsic propensity of cortical neurons to fall into
silent hyperpolarized OFF-periods, which result in high-amplitude EEG
slow-waves, both spontaneous and evoked by perturbations (Sarasso
et al., 2015; Pigorini et al., 2015). Neuronal bistability has been thor-
oughly assessed in the realm of sleep physiology across different species
and models. In this respect, in silico, in vitro as well as in vivo animal
models suggests that neuronal bistability, and the ensuing activity
dampening, may be due to adaptation mechanisms, such as neuronal
disfacilitation (Compte, 2003; Sanchez-Vives and McCormick, 2000) as
well as active inhibition (Funk et al., 2017; Zucca et al., 2017).
Altogether, neuronal bistability—mediated by 2 PKþ agonism—-
alone or in combination with increased excitation—mediated by NMDA
receptor antagonism—may explain the prominent slowing of the EEG
across the 1–40Hz range and the steeper decay of the PSD during xenon.
4.5. Spectral exponent and mechanisms of action: ketamine
During ketamine, the spectral exponent β decreased slightly over the640broad-band and, more pronouncedly, over the low-band, in all but one
subject. This pattern is consistent with increased low-frequency power in
the delta and theta band (Vlisides et al., 2017; Akeju et al., 2016; Wang
et al., 2017). However, the broad-band spectral exponent across partic-
ipants during ketamine was found widely overlapping with that of
wakefulness (Fig. 4A). This is consistent with the preservation of
conscious experience, despite profound unresponsiveness induced by the
drug.
Moreover, in contrast to the other conditions (wakefulness, xenon-
and propofol-anesthesia), during ketamine the PSD changed differently
in the two portions of the spectrum. Speciﬁcally, while the PSD steepened
in the low-band in all but one subject, the PSD markedly ﬂattened in the
high-band in all subjects (Fig. 4B). A remarkably similar shape of the PSD
background in the two bands can be observed in previous EEG studies of
ketamine anesthesia (Vlisides et al., 2017; Akeju et al., 2016; Maksimow
et al., 2006). In addition, ketamine, even at subanesthetic doses (i.e.
behavioural responsiveness maintained), differently affected two por-
tions of the MEG spectrum (Muthukumaraswamy and Liley, 2018) in a
similar fashion to that observed here.
It is conceivable that these changes in the shape of the PSD back-
ground can reﬂect the underlying mechanism of action of ketamine.
Indeed ketamine acts primarily by binding to N-methyl-D-aspartate
(NMDA) receptors, more effectively on interneurons than on pyramidal
neurons (Purdon et al., 2015; Akeju et al., 2016). This results in
down-regulation of the inhibitory tone, and thereby in higher excitability
of pyramidal neurons, potentially explaining shallower slope and larger
power in the high-frequency band. This is furthermore consistent with
ketamine-induced increase of cerebral glucose consumption and blood
ﬂow (Langsjo et al., 2004; Långsj€o et al., 2005). Regarding the lower end
of the spectrum, animal studies (Miyasaka and Domino, 1968; Kayama
and Iwama, 1972; Kiss et al., 2011; Zhang et al., 2012) suggest that the
thalamus may play an essential role in the generation of low-frequency
activity observed during ketamine. Speciﬁcally, NMDA-blockade medi-
ated thalamic bursting may induce both theta and sporadic delta rhythms
recorded with scalp EEG (Sarasso et al., 2015; Akeju et al., 2016). This
may explain our observation of consistent, albeit non-signiﬁcant, low--
frequency steepening during ketamine anesthesia.
4.6. Ketamine temporal diversity: high-frequency arrhythmic activity
A ﬂatter decay of the PSD indexes a reduction in temporal autocor-
relations (He, 2014). Therefore, a near-ﬂat decay of the PSD over the
20–40Hz during ketamine anesthesia is consistent with the observation
of increased temporal diversity of MEG signals during ketamine sedation
(Schartner et al., 2017) and EEG signals during ketamine anesthesia
(Wang et al., 2017). In these studies, temporal diversity was estimated
with information-theoretic measures that rely upon binarization of the
signal, according to the crossings around the mean/median of short
epochs. Because high-frequency activity has an inherent high chance of
crossing the mean/median, we reason that the observed higher signal
diversity due to ketamine action in both studies is primarily due to the
arrhythmic crossings of high-frequency activity. Conversely, in propofol,
a steeper decay of the PSD could be interpreted as increased temporal
autocorrelations (i.e. redundancy) (He, 2014), which is consistent with
decreased randomness of EEG signals during propofol anesthesia (Wang
et al., 2017). Conceivably, the same more ordered behaviour is to be
expected for xenon anesthesia, despite no studies could be found up to
date.
4.7. A steeper broad-band spectral exponent discriminate unconsciousness
from consciousness
We have shown that the spectral exponent distinguished the ‘No
report’ conditions (propofol and xenon anesthesia) from the ‘Conscious
report’ conditions (wakefulness, ketamine anesthesia) in all cases and
irrespectively of inter-individual differences in the spectral exponent.
M.A. Colombo et al. NeuroImage 189 (2019) 631–644This is valuable, since conscious experiences are often not reliably
detected by common proprietary EEG-based anesthesia monitors (Rus-
sell, 2006; Samuelsson et al., 2008; Schneider et al., 2002). In the
‘Conscious report’ conditions, across wakefulness and ketamine anes-
thesia, the broad-band spectral exponent assumed values ~ -1 (β, mean
[range]: 1.14 [-1.75, 0.74]). This ﬁnding is consistent with previous
EEG (Dehghani et al., 2010; Pereda et al., 1998; Susmakova, 2006) and
MEG observations during wakefulness and ketamine sedation (Novikov
et al., 1997; Muthukumaraswamy and Liley, 2018) as well as with MEG
observations during the psychedelic drug LSD (Muthukumaraswamy and
Liley, 2018). In contrast, in the ‘No report’ conditions (xenon and pro-
pofol anesthesia), the PSD showed a steeper decay across a broad band of
frequencies (1–40 Hz). A steep PSD in the ‘No report’ condition was
indexed by a large and negative spectral exponent, β< 2 (Fig. 4A). This is
consistent with a slowing of the EEG and a redistribution of spectral
power towards lower frequencies, typically observed in general anes-
thesia (Brown et al., 2010; Murphy et al., 2011; Laitio et al., 2008; Tonner
and Bein, 2006).
4.8. Convergent validity: correlation with the perturbational complexity
index
Finally, our results showed robust positive correlation between the
spectral exponent of spontaneous activity and the Perturbational
Complexity Index (PCI), obtained contextually over the same individuals
(Sarasso et al., 2015). PCI is an empirical measure for the spatiotemporal
EEG dynamics evoked by TMS, aimed at quantifying the joint presence of
integration and differentiation (Casali et al., 2013), a fundamental
requirement for the emergence of consciousness (Tononi and Edelman,
1998).
As discussed above, the spectral exponent has a tight relationship to
the excitation and inhibition balance—as also supported by empirical
and modelling evidence (Gao et al., 2017; Lombardi et al., 2017). The
neural mechanisms balancing excitation and inhibition tightly regulate
the proximity to a critical transition between activity propagation and
extinction (Poil et al., 2012; Hellyer et al., 2016). Self-sustaining neural
dynamics poised near criticality maximize the joint presence of integra-
tion and differentiation (Tagliazucchi, 2017). It is therefore compelling
that both the spectral exponent and PCI peaked for states where excita-
tion approximately balances inhibition—wakefulness and ketamine
anesthesia—and were the lowest for states where the balance is dis-
rupted—propofol and xenon anesthesia. This behaviour suggests a po-
tential link between the spectral exponent and critical dynamics.
4.9. Scaling properties in different frequency bands
In the current study, we considered the overall decay of the back-
ground of the PSD over the 1–40Hz range, thus encompassing all classic
frequency bands of the EEG. The PSD decay was even more accurately
described when considering the scaling properties of two adjacent sub-
bands (1–20 Hz, 20–40Hz), due to a bend or ‘knee’ at ~20Hz. A sin-
gular scaling regime should be observed for at least two-orders of
magnitude for both x and y axis, in order to have the statistical support to
declare that a genuine power-law relationship exists (Stumpf and Porter,
2012). A power-law distribution is a classical signature of criticality (Bak
et al., 1987). Recently, the framework has been extended to account for
different scaling regimes in the power spectrum. For instance, one study
introduced a dissipation factor to an activation/deactivation process,
resulting in a bend or ‘knee’ in the PSD shape (De Los Rios and Zhang,
1999). Another study observed different scaling regions in the PSD of
ECoG activity resulting from a slow/distributed and a fast/local mode of
balanced activity propagation, as modelled by neural networks with
recurrent random connectivity (Chaudhuri et al., 2018). A more realistic,
physiologically constrained, corticothalamic model of the EEG was able
to reproduce the sleep-related steepening of the 1/f-like decay in the low
frequencies, and attributed the PSD ‘knee’ at ~20Hz—as well as the641steeper decay at higher frequencies—to the low-pass ﬁltering properties
of the dendrites (Robinson et al., 2001, 2011). Consistently, we here
observed a steeper decay of the PSD in the high-frequencies during
wakefulness as well as during xenon and propofol. Conversely, ketamine
produced a remarkable ﬂattening in the high-frequencies, independently
from the low-frequencies (Vlisides et al., 2017; Akeju et al., 2016;
Maksimow et al., 2006). A ﬂatter PSD slope in high-frequencies encom-
passing the gamma range, as compared to the slope in the low fre-
quencies, has been previously observed also in the human LFP (Freeman
and Zhai, 2009). This upward deﬂection above a ‘knee’ frequency
(around ~20Hz) has been modelled by adding to the 1/f-like signal a
ﬂat-spectrum signal—proposed to represent the aggregate spiking ac-
tivity of local neuronal populations (Gao, 2016).
We warrant caution in generalizing the results to different recording
set-ups and experimental models, where different scaling regimes could
be observed. Comparisons across studies should be carefully undertaken,
also due the different frequency ranges under scrutiny. For instance, due
to the problem of ﬁtting a power-law where oscillations are present, the
empirical studies in (Gao et al., 2017) select a range of frequencies be-
tween 30 and 70 Hz. However, the computational model presented in
(Gao et al., 2017) suggests a tighter relationship between the E/I and the
PSD slope over the 10–30Hz and the 20–40Hz range. Indeed, several
studies observed that sleep depth decreased the spectral exponent, esti-
mated from low to high frequencies (He et al., 2010; Freeman and Zhai,
2009; Pereda et al., 1998; Freeman, 2006; Susmakova, 2006). However,
the EEG spectral scaling exponent of infra-slow frequencies decreased
with sleep depth (Lei et al., 2014)—yielding a shallower decay of the PSD
over 0.06–3 Hz—thus revealing an opposite pattern to that typically
observed at higher frequencies. Future studies should investigate the
relationship between scaling exponents across a wide frequency range,
while devising solid strategies to minimize the inﬂuence of physiolog-
ical-, movement- and apparatus-induced artifacts (see Supplementary
Material, section 7, for a detailed discussion on the potential contami-
nation from ocular and muscular artifacts).4.10. Future directions: intraoperative awareness, dreams and disorders of
consciousness
PCI has shown to be a reliable marker for the presence of con-
sciousness in brain-injured patients with disorders of consciousness
(Casali et al., 2013; Casarotto et al., 2016). Given the robust positive
correlation between PCI and the spectral exponent observed here, future
work should test the ability of the spectral exponent in highlighting the
presence of -and the recovery of-consciousness in brain-injured unre-
sponsive patients. Concerning pharmacological manipulations, such as
those here investigated, it would be also interesting to assess changes in
the spectral exponent during the transition to unconsciousness. Along
these lines, studies employing time-resolved EEG measures, such as the
Direct Transfer Function, have shown the potential to track the transition
from/to unconsciousness induced by anesthetic agents (Juel et al., 2018).
Similarly, the spectral exponent can also be computed in a time-resolved
fashion (Supplementary Material, section 8; Supplementary Figs. 8 and
9), thus showing the potential for real time monitoring of
anesthesia-induced unconsciousness. Indeed, in this context, careful
experimental settings should be designed in the attempt to systematically
disentangle concentration-speciﬁc effects from proper changes in the
level of consciousness (Radek et al., 2018; Scheinin et al., 2018b).
Furthermore, it is expected that the spectral exponent should also be
sensitive to the physiological ﬂuctuations of the state of consciousness
occurring during natural sleep, both across (Fagioli et al., 1989) as well as
within speciﬁc sleep stages (Siclari et al., 2017).
In conclusion, the spectral exponent has proven across three different
anesthetics to be a very promising feature, with both practical and
theoretical implications, to index the presence of consciousness beyond
sheer unresponsiveness.
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